Medtronic plc MDT

Rank #1008 · NYSE · $123.6B market cap

Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.

Score

54.8

P/E

33.6

P/B

2.57

ROE

7.7%

Op. Margin

15.9%

Debt Ratio

90%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆

Average

P/E 33.6x, P/B 2.57x. Ranks in the top 45% of the universe.

Profitability ★★★☆☆

Good

ROE 7.7%. Ranks in the top 40% of the universe.

Safety ★★★☆☆

Good

Debt ratio 90%. Ranks in the top 36% of the universe.

Growth ★★☆☆☆

Average

Revenue growth of 3.6% year over year. Ranks in the top 54% of the universe.

Valuation is the relative strength · Growth is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2015	–	$4.4B	$3.5B	$17.1B	–	108
2016	–	$3.8B	$3.1B	$18.7B	–	286
2017	–	$3.8B	$2.7B	$52.1B	–	91
2018	–	$5.4B	$3.5B	$50.2B	–	99
2019	$29.7B	$5.4B	$4.0B	$50.7B	18.1	80
2020	$30.0B	$6.6B	$3.1B	$50.1B	22.2	79
2021	$30.6B	$6.3B	$4.6B	$50.7B	20.5	78
2022	$28.9B	$4.8B	$4.8B	$51.4B	16.6	81
2023	$30.1B	$4.5B	$3.6B	$52.6B	14.9	73
2024	$31.7B	$5.8B	$5.0B	$51.5B	18.2	76
2025	$31.2B	$5.5B	$3.8B	$50.2B	17.6	79
2026	$32.4B	$5.1B	$3.7B	$48.0B	15.9	90